Literature DB >> 16487589

B-1 cells express transgelin 2: unexpected lymphocyte expression of a smooth muscle protein identified by proteomic analysis of peritoneal B-1 cells.

Rubén Francés1, Joseph R Tumang, Hiroaki Kaku, Sean M Gurdak, Thomas L Rothstein.   

Abstract

B-1 cells constitute a unique B cell subset that differs phenotypically, biochemically, and functionally from the predominant population of conventional B-2 cells. Functional differences include constitutive secretion of natural immunoglobulin and failure of BCR signaling to initiate proliferation. The origin of these differences remains uncertain. We hypothesized that unbiased analysis of differences in protein expression between highly pure populations of B-1 and B-2 cells might provide information not readily available through other means. To pursue this, we undertook 2D gel analysis of B-1 and B-2 cells combined with mass spectrometry. We identified the smooth muscle protein, transgelin 2, in peritoneal (but not splenic) B-1 cells and did not find it in splenic B-2 cells; these results were confirmed by Western blot analysis, which showed a more than 60-fold difference in transgelin 2 expression between peritoneal B-1 and splenic B-2 cells. In contrast, levels of transgelin 2 RNA differed to a much lesser extent (3-fold) in the two B cell populations, so transgelin 2 is an example of a molecule whose subset-specific expression is more readily detected by proteomic than transcriptomic analyses. Finally, transgelin 2 protein expression was induced in splenic B-2 cells; thus, transgelin 2 joins a number of other inducible molecules that are constitutively expressed by peritoneal B-1 but not splenic B-2 cells. Although the role of transgelin 2 in B-1 cell function remains uncertain, identification of this molecule demonstrates the value of examining protein expression in this B cell subset.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487589     DOI: 10.1016/j.molimm.2005.12.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  Proteomic analyses of human plasma: Venus versus Mars.

Authors:  Christopher C Silliman; Monika Dzieciatkowska; Ernest E Moore; Marguerite R Kelher; Anirban Banerjee; Xiayuan Liang; Kevin J Land; Kirk C Hansen
Journal:  Transfusion       Date:  2011-08-31       Impact factor: 3.157

Review 2.  Transgelin-2: Biochemical and Clinical Implications in Cancer and Asthma.

Authors:  Lei-Miao Yin; Luis Ulloa; Yong-Qing Yang
Journal:  Trends Biochem Sci       Date:  2019-06-27       Impact factor: 13.807

3.  Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells.

Authors:  Nichol E Holodick; Joseph R Tumang; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2009-07-09       Impact factor: 4.407

Review 4.  Human B-1 cells take the stage.

Authors:  Thomas L Rothstein; Daniel O Griffin; Nichol E Holodick; Tam D Quach; Hiroaki Kaku
Journal:  Ann N Y Acad Sci       Date:  2013-05       Impact factor: 5.691

5.  CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes.

Authors:  Trivikram Dasu; Vishal Sindhava; Stephen H Clarke; Subbarao Bondada
Journal:  Mol Immunol       Date:  2009-06-21       Impact factor: 4.407

6.  Transgelin-2 in B-Cells Controls T-Cell Activation by Stabilizing T Cell - B Cell Conjugates.

Authors:  Bo-Ra Na; Min-Sung Kwon; Myoung-Won Chae; Hye-Ran Kim; Chang-Hyun Kim; Chang-Duk Jun; Zee-Yong Park
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

7.  The evolutionary origin of bilaterian smooth and striated myocytes.

Authors:  Thibaut Brunet; Antje Hl Fischer; Patrick Rh Steinmetz; Antonella Lauri; Paola Bertucci; Detlev Arendt
Journal:  Elife       Date:  2016-12-01       Impact factor: 8.140

8.  Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.

Authors:  Kaori Kiso; Hajime Yoshifuji; Takuma Oku; Masaki Hikida; Koji Kitagori; Yoshitaka Hirayama; Toshiki Nakajima; Hironori Haga; Tatsuaki Tsuruyama; Aya Miyagawa-Hayashino
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

9.  A CD25⁻ positive population of activated B1 cells expresses LIFR and responds to LIF.

Authors:  Joseph R Tumang; Nichol E Holodick; Teresa C Vizconde; Hiroaki Kaku; Rubén Francés; Thomas L Rothstein
Journal:  Front Immunol       Date:  2011-03-21       Impact factor: 7.561

10.  Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.

Authors:  Yan Sun; Wenfang Peng; Weiwei He; Man Luo; Guilin Chang; Jiping Shen; Xiaoping Zhao; Yu Hu
Journal:  J Exp Clin Cancer Res       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.